HOB Biotech Group Corp Ltd Cash Flow Quality Index
HOB Biotech Group Corp Ltd cash flow quality index. HOB Biotech Group Corp Ltd (688656) has a Cash Flow Quality Index of 2.45x as of September 2025. Operating cash flow of CN¥34.39 Million exceeds net income of CN¥14.02 Million, indicating high earnings quality where cash backs reported profits. Explore 688656 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of HOB Biotech Group Corp Ltd (2016–2025)
Cash flow quality index of HOB Biotech Group Corp Ltd from 2016 to 2025. Historical Cash Flow Quality Index for HOB Biotech Group Corp Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. See HOB Biotech Group Corp Ltd (688656) balance sheet quality index to measure how much of total assets are equity-financed.
HOB Biotech Group Corp Ltd Cash Flow Quality Index by Year (2016–2025)
HOB Biotech Group Corp Ltd cash flow quality index by year from 2016 to 2025. Year-by-year earnings quality comparison for HOB Biotech Group Corp Ltd. For the full cash flow conversion analysis, see HOB Biotech Group Corp Ltd operating cash flow efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.14x | CN¥72.94 Million | CN¥23.20 Million | ▲ +14.3% |
| 2024 | 2.75x | CN¥101.22 Million | CN¥36.80 Million | ▲ +26.8% |
| 2023 | 2.17x | CN¥102.69 Million | CN¥47.33 Million | ▲ +55.0% |
| 2022 | 1.40x | CN¥58.31 Million | CN¥41.65 Million | ▲ +15.1% |
| 2021 | 1.22x | CN¥104.79 Million | CN¥86.19 Million | ▲ +18.2% |
| 2020 | 1.03x | CN¥58.22 Million | CN¥56.62 Million | ▼ -4.3% |
| 2019 | 1.07x | CN¥68.57 Million | CN¥63.84 Million | ▼ -7.3% |
| 2018 | 1.16x | CN¥46.51 Million | CN¥40.15 Million | ▲ +11.1% |
| 2017 | 1.04x | CN¥22.26 Million | CN¥21.35 Million | ▼ -29.6% |
| 2016 | 1.48x | CN¥6.42 Million | CN¥4.34 Million | — |